Search & Analyze
Popular Searches
Nephro Care India Ltd.
Healthcare₹63.70
CMP₹63.70
Mkt Cap₹105 Cr
P/E31.17
P/B1.85
ROE10.62%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
31.17
P/B Ratio
1.85
EV/EBITDA
9.99
Price/Sales
1.18
Dividend Yield (%)
0.00
EPS (TTM ₹)
2.04
Book Value (₹)
34.48
ROE (%)
10.62
ROCE (%)
14.42
ROA (%)
8.16
EBITDA Margin (%)
12.76
Net Profit Margin (%)
7.91
Debt/Equity
0.00
Current Ratio
2.01
Interest Coverage
44.86
Asset Turnover
1.03
Working Capital/Sales
3.24
Core EBITDA Growth (%)
8.24
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 182.48 | 342.44 | 1709.27 | 2723.08 | 4603.11 |
| Net Sales | 182.48 | 342.44 | 1709.27 | 2723.08 | 4603.11 |
| Total Income | 183.26 | 342.7 | 1709.48 | 2760.08 | 4755.8 |
| Total Expenditure | 167.02 | 329.88 | 1366.76 | 2076.47 | 4015.85 |
| Operating Profit | 16.24 | 12.82 | 342.72 | 683.61 | 739.95 |
| Depreciation | 1.3 | 11.14 | 78.43 | 52.76 | 246.01 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 11.79 | 0.02 | 257.72 | 622.34 | 482.93 |
| Tax | 2.92 | 1 | 20.47 | 172.1 | 119.04 |
| Profit After Tax (PAT) | 8.87 | -0.98 | 237.25 | 450.24 | 363.89 |
| EPS (₹) | 4.44 | -0.03 | 2.37 | 3.8 | 2.38 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1 | 50 | 50 | 1190.24 | 1648.64 |
| Reserves | 0.5 | -0.48 | 202.87 | 312.29 | 3699.81 |
| Shareholders Funds | 1.5 | 49.52 | 252.87 | 1502.53 | 5348.45 |
| Total Debt | 69.27 | 253.74 | 248.15 | 0 | 0 |
| Total Liabilities | 112.55 | 462.93 | 816.65 | 2088.25 | 6828.45 |
| Total Assets | 112.55 | 462.93 | 816.65 | 2088.25 | 6828.45 |
| Book Value / Share | 15 | 9.904 | 50.574 | 12.6238 | 32.4416 |
| Assets | 112.55 | 462.93 | 816.65 | 2088.25 | 6828.45 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 22.7 | 61.73 | 412.19 | 91.08 | 782.42 |
| Investing Activities | -6.32 | -281.06 | -233.28 | -753.92 | -3955.69 |
| Financing Activities | 27.75 | 232.01 | -8.15 | 560.24 | 3510.05 |
| Net Cash Flow | 44.13 | 12.68 | 170.76 | -102.6 | 336.78 |
NEPHROCARE
₹63.70
+0%